Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shire Pharmaceuticals Ireland Ltd.

www.shire.com

Latest From Shire Pharmaceuticals Ireland Ltd.

Takeda’s Maribavir For Post-Transplant Cytomegalovirus Might See Split Panel Vote

First-in-class CMV treatment showed better efficacy in refractory patients with genetic resistance than those without; US FDA advisory committee will separately consider benefit-risk in each type of patient. On the safety side, taste disturbance is the only adverse event that stands out.

Advisory Committees Drug Review
See All

Company Information

UsernamePublicRestriction

Register